Market Research Logo

Oncology Drugs Market Global Briefing 2018 Including: Oncology Drugs, Drugs For Blood Cancer, Breast Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Kidney Cancer, Colorectal Cancer, Thyroid Cancer, Non-Small Cell Lung Cancer, Gastric Cancer, Brain

Oncology Drugs Market Global Briefing 2018 Including: Oncology Drugs, Drugs For Blood Cancer, Breast Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Kidney Cancer, Colorectal Cancer, Thyroid Cancer, Non-Small Cell Lung Cancer, Gastric Cancer, Brain Tumor, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Bladder Cancer and Others.Covering: F. Hoffmann-La Roche Ltd., Novartis AG, Gilead Sciences, Inc., Bayer AG, Takeda Pharmaceuticals, Johnson & Johnson, Pfizer Inc., Boehringer Ingelheim GmbH, Eli Lilly And Company, Otsuka Pharmaceutical Co., Ltd.

North America was the largest region in the oncology drugs market in 2017, accounting for around 31% market share. North America has the highest GDP that allows it to afford the latest and patented oncology medicines which are comparatively higher or difficult to access when compared with other regions. Asia Pacific was the second largest region accounting for around 25% market share. Middle East was the seventh largest region accounting for around 4% market share.

Oncology Drugs Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global oncology drugs sector.

Reasons to Purchase

  • Fully updated for 2018.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Oncology Drugs Market Global Briefing 2018 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the oncology drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the oncology drugs market and suggests approaches.

Scope

Markets Covered: Blood Cancer, Breast Cancer, Cervical Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Kidney Cancer, Gastric Cancer, Brain Tumor, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Bladder Cancer, Thyroid Cancer, Others.

Companies Mentioned: F. Hoffmann-La Roche Ltd., Novartis AG, Gilead Sciences, Inc., Bayer AG, Takeda Pharmaceuticals, Johnson & Johnson, Pfizer Inc., Boehringer Ingelheim GmbH, Eli Lilly And Company, Otsuka Pharmaceutical Co., Ltd.

Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Oncology Drugs Market Characteristics
Oncology Drugs Market Historic Growth (2013-17)
Oncology Drugs Market Forecast Growth (2017-21)
Oncology Drugs Market Segmentation
Global Oncology Drugs Market, Split By Segments, 2017, $ Billion
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others
Global Oncology Drugs Market, Historic and Forecast, Split By Segments, 2013-2021
Oncology Drugs Market Geography Regional and Country Comparison
Global Oncology Drugs Market, Split By Regions, 2017
Global Oncology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021
Global Oncology Drugs Market, Split By Country, 2017
Global Oncology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021
Oncology Drugs Market Competitive Landscape
F. Hoffmann-La Roche Ltd.
Novartis AG
Gilead Sciences, Inc.
Bayer AG
Takeda Pharmaceticals
Johnson & Johnson
Pfizer Inc.
Boehringer Ingelheim GmbH
Eli Lilly And Company
Otsuka Pharmaceutical Co., Ltd.
F.Hoffmann-La Roche
Novartis
Gilead Sciences, Inc.
Oncology Drugs Market Key Mergers And Acquisitions
Novartis Acquired GSK’s Oncology
Pfizer Acquired Medivation
Takeda Pharmaceutical Company Acquires ARIAD Pharmaceuticals, Inc.
Roche Acquired Seragon
Jazz Pharmaceuticals Acquired Celator
Sumitomo Dainippon Pharma Co. Ltd. Acquires Tolero Pharmaceuticals
Ipsen Acquires Oncology Assets From Merrimack Pharmaceuticals
Celldex Therapeutics Acquires Kolltan Pharmaceuticals
Merck Acquired OncoEthix
NeoGenomics Acquired Clarient
Merger Of Threshold Pharmaceuticals With Molecular Templates, Inc.
Definitive Merger Of Achieve Life Science, Inc. By OncoGenex Pharmaceuticals, Inc.
Oncology Drugs Market Trends And Strategies
Collaboration Driving Innovation
Biomarker Driven R&D
Increasing Demand For Personalized Medicines
Appendix
NAICS Definitions Of Industry Covered In This Report
Definition Of Market Covered In This Report
Abbreviations
Currencies
Research Methodology
Research Inquiries
The Business Research Company
List of Figures
Figure 1: Global Oncology Drugs Market, Historic Market Size, 2013-2017, $ Billion
Figure 2: Global Oncology Drugs Market, Forecast Market Size, 2017 – 2021, $ Billion
Figure 3: Global Oncology Drugs Market, Split By Segments, 2017, $ Billion
Figure 4: Global Oncology Drugs Market, Historic and Forecast, Split By Segment, 2013 – 2021
Figure 5: Global Oncology Drugs Market, Split By Region, 2017, $ Billion
Figure 6: Global Oncology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021
Figure 7: Global Oncology Drugs Market, Split By Country, 2017, $ Billion
Figure 8: Global Oncology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021
Figure 9: Global Oncology Drugs Market, Key Competitor Estimated Market Shares, 2017, Percentage (%)
List of Tables
Table 1: Global Oncology Drugs Market, Historic Market Size, 2013-2017, $ Billion
Table 2: Global Oncology Drugs Market, Forecast Market Size, 2017 – 2021, $ Billion
Table 3: Global Oncology Drugs Market, Split By Segments, 2017, $ Billion
Table 4: Global Oncology Drugs Market, Historic and Forecast, Split By Segment, 2013 – 2021
Table 5: Global Oncology Drugs Market, Split By Region, 2017, $ Billion
Table 6: Global Oncology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021
Table 7: Global Oncology Drugs Market, Split By Country, 2017, $ Billion
Table 8: Global Oncology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021
Table 9: Global Oncology Drugs Market, Key Competitor Estimated Market Shares, 2017, Percentage (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report